Orthofix International to Participate in JP Morgan 29th Annual Healthcare Conference

January 6, 2011

LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that it will participate in JP Morgan's 29th Annual Healthcare Conference in San Francisco.

Chief Executive Officer Alan Milinazzo is scheduled to give a presentation on Wednesday, January 12th, at 7:30 PM Eastern Time at the Westin St. Francis Hotel.

A live audio webcast of the presentation will be available on the Company's website at www.orthofix.com by clicking on the Investors tab and then clicking the link on the Events & Presentations page.

About Orthofix International, N.V.

Orthofix International, N.V. is a global medical device company offering a broad line of minimally invasive surgical, and non-surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages—helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons and patients via Orthofix's sales representatives and its subsidiaries, including BREG, Inc. and via partnerships with other leading orthopedic product companies. In addition, Orthofix collaborates with leading medical institutions such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and The University of Medicine and Dentistry of New Jersey. For more information about Orthofix, please visit www.orthofix.com.

Orthofix International N.V.
Dan Yarbrough, 214-937-2900
Vice President of Investor Relations
danyarbrough@orthofix.com

Source: Orthofix International N.V.

News Provided by Acquire Media